Industry

Program empowers partner organizations to integrate ready-to-use, provider cost and quality metrics directly into their databases and applications ARLINGTON, Va.–(BUSINESS WIRE)–CareJourney, a market leader in provider cost and quality data, today announced its growing partner program that combines the power of CareJourney’s national-level performance dataset with the solutions and expertise of its best-in-class partners to … [Read more…]

Enterprise imaging platform, Butterfly Blueprint™, now empowers emergency physicians, and other ultrasound users, to direct and manage ultrasound utilization and proficiency See Butterfly’s New Proficiency Management Solution at ACEP22 in booth #1208 BURLINGTON, Mass. & SAN FRANCISCO–(BUSINESS WIRE)–Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly”), a digital health company transforming care through the power of handheld, whole-body … [Read more…]

Q2-Fiscal 2023 Revenues of $3.6m Increased 87% over Q2-Fiscal 2022 Q2-Fiscal 2023 Clinic Operations Revenue increased 198% over Q2-Fiscal 2022 TORONTO–(BUSINESS WIRE)–Jack Nathan Medical Corp. (TSXV: JNH, OTCQB: JNHMF) (“Jack Nathan Health”, “JNH” or the “Company”) announced today its unaudited interim consolidated annual financial results for the second quarter of fiscal 2023. Jack Nathan Health’s … [Read more…]

NASHVILLE, Tenn.–(BUSINESS WIRE)–HCA Healthcare, Inc. (NYSE: HCA) announces the following Webcast: What: HCA Healthcare, Inc. 3Q Earnings Release Call When: Friday, October 21, 2022 at 8:00 am central (9:00 am eastern) How: Live Audio over the Internet: https://investor.hcahealthcare.com/events-and-presentations/default.aspx If you are unable to listen during the live webcast, the call will be archived on the … [Read more…]

Intends to Cure Deficiency and Return to Compliance with NYSE Listing Standard ELYRIA, Ohio–(BUSINESS WIRE)–Invacare Corporation (NYSE: IVC) today announced that it received notice from the New York Stock Exchange (the “NYSE”) that the company is not in compliance with Section 802.01C of the NYSE Listed Company Manual because the average closing price of the … [Read more…]

Organization Successfully Closes $13.5M “Unlock Potential” Capital Campaign Ribbon-Cutting Ceremony Marks Major Milestone and Honors Partnership with the Golden Valley Community GOLDEN VALLEY, Minn.–(BUSINESS WIRE)–Franklin Center, Minnesota’s only comprehensive education and services center for those on the autism spectrum or with other neurodiversities, celebrates its new campus and new name with a ribbon-cutting ceremony on … [Read more…]

Announces second-quarter fiscal 2023 earnings release date IRVING, Texas–(BUSINESS WIRE)–McKesson Corporation (NYSE: MCK) today announced that it has signed an agreement in principle to extend its partnership with CVS Health to distribute pharmaceuticals to mail order and specialty pharmacies, retail pharmacies and distribution centers through June 2027. “We are pleased to continue our long-standing relationship … [Read more…]

TTHX1114 has the potential to be the first pharmacologic treatment for corneal endothelial dystrophies CHICAGO–(BUSINESS WIRE)–Trefoil Therapeutics, a clinical-stage biotechnology company focused on restoring sight to people with corneal diseases, today announced positive Phase 2 results for TTHX1114 in patients with Fuchs Endothelial Corneal Dystrophy (FECD). TTHX1114, a proprietary engineered fibroblast growth factor-1 (FGF1) variant, … [Read more…]

ALAMEDA, Calif.–(BUSINESS WIRE)–#CRISPR–Scribe Therapeutics Inc., a molecular engineering company pioneering a CRISPR by Design™ platform for genetic medicine, today announced it will participate in two upcoming investor conferences: Scribe co-founder and CEO Benjamin Oakes will participate in a panel titled “Gene Editing: Next-Generation Technologies Worth Watching,” at 9:30 a.m. ET on Oct. 3, 2022, at … [Read more…]

Sitagliptin is an active ingredient in JANUVIA®, JANUMET® and JANUMET® XR RAHWAY, N.J.–(BUSINESS WIRE)–$MRK #MRK–Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that the U.S. Court of Appeals for the Federal Circuit ruled in favor of the company in a patent challenge brought by Mylan Pharmaceuticals, Inc. (now … [Read more…]